Ebola prevention trial enrolls over 250 in Congo

· Health · DR Congo

More than 250 participants have enrolled in a trial of a drug that could stop people from contracting Ebola in Congo. Experts described it as a critical step against the deadliest outbreak of the disease in the Central African country.

Why it matters：A preventive Ebola trial in Congo could change outbreak containment strategies and global stockpile planning.

Key points

  • More than 250 participants are enrolled.
  • The trial tests a drug meant to prevent Ebola infection.
  • Congo is facing its deadliest Ebola outbreak.

Sources (original reporting)

More stories from this day